In a trial, empagliflozin reduced the risks for heart failure hospitalization and renal outcomes in patients with heart failure with reduced ejection fraction.
As cardiorespiratory fitness declines among US youth, researchers explore methods for assessing cardiorespiratory fitness in otherwise healthy children.
Cardiac injury and shock can occur in pediatric patients with COVID-19.
The American College of Cardiology has released guidance on pediatric return-to-play for sports participation following COVID-19 infection.
For anti-SSA/Ro-positive mothers with a previous pregnancy complicated by congenital heart block (CHB), hydroxychloroquine may reduce the recurrence of CHB.
Researchers evaluated blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus.
Higher blood pressure is connected to narrowing of retinal arterioles in young children.
Changes have been suggested for the newborn critical congenital heart disease (CCHD) screening algorithm.
Prehospital administration of epinephrine may aid pediatric patients following out-of-hospital cardiac arrests.
The FDA has approved Lumason, an ultrasound enhancing agent, for use in echocardiography to opacify the left ventricular chamber.